Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era

By Ung J.O.   Richie J.P.   Chen M.-H.   Renshaw A.A.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 458-463

Elsevier

Access to resources Recommend Favorite

Investigative clinical study on prostate cancer: on the role of the pretreatment total PSA to free testosterone ratio in selecting different biology groups of prostate cancer patients

By Porcaro Antonio   Migliorini Filippo   Romano Mario   Petrozziello Aldo   Antoniolli Stefano   Rubilotta Emanuele   Lacola Vincenzo   Sava Teodoro   Ghimenton Claudio   Caruso Beatrice   Monaco Carmelo   Comunale Luigi  

International Urology and Nephrology, Vol. 42, Iss. 3, 2010-09 ,pp. : 673-681

Springer Publishing Company

Access to resources Recommend Favorite

Does PSA Testing Influence the Natural History of Prostate Cancer?

By Anderson J.  

European Urology Supplements, Vol. 1, Iss. 5, 2002-08 ,pp. : 3-10

Elsevier

Access to resources Recommend Favorite

Benign growth of different prostate zones in aging men with slightly elevated PSA in whom prostate cancer has been excluded: a prospective study of 510 patients

By Gjengsto P.   Halvorsen O.J.   Akslen L.A.   Frugard J.   Hoisaeter P.A.  

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 447-450

Elsevier

Access to resources Recommend Favorite

Prostate-specific Antigen (PSA), PSA Density and Age-adjusted PSA Reference Values in Screening for Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men

By Gustafsson Ove   Mansour Essam   Norming Ulf   Carlsson Adelaida   Törnblom Magnus   Nyman Claes R.  

Scandinavian Journal of Urology and Nephrology, Vol. 32, Iss. 6, 1998-12 ,pp. : 373-377

Informa Healthcare

Access to resources Recommend Favorite